VALNEVA

General information

World Trade Center Lyon - Tour Oxygène, 10-12 boulevard Marius Vivier Merle

69003 LYON

Incorporated in: 2013/05/27

Number of employees: 400


More information

 

Main activity

As a commercial stage biotech company, Valneva’s mission is to help protect the lives of people around the world through the discovery, development and commercialization of innovative vaccines against infectious diseases. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease. Valneva aims to become the leading vaccine biotech company by complementing product sales growth with the development of high value R&D assets. More information is available at www.valneva.com.


Funding

Looking for funding: Yes

Stock exchange listing: Valneva, headquartered in Lyon, is listed on Euronext-Paris and the Vienna Stock Exchange and is tradable on Deutsche Börse’s electronic platform, Xetra. The Company has operations in France, Austria, Sweden, the UK, the US and Canada with over 400 employees.

Segmentation
Activities

Strategic area of application
Human Medicine


Application market
Infectiology - Parasitology - Others


Activities
Therapeutics, Pharma or Biotech


Technologies
Vaccine

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree